We Address Unmet Medical Needs to Improve Patient Outcomes and Quality of Life


Abiogen Pharma Completes the Acquisition of Effrx

Our Products

The product portfolio is led by already commercialized Binosto® for the treatment of postmenopausal osteoporosis.

Partnering with us

Our strategy relies on partnerships for shared commercial success.
Scroll to Top